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 Instructions for Authors 
 
General Information  
Journal of Translational Internal Medicine, an official journal of the International Society of 
Translational Sciences, Infectious Diseases Society of China, Internal Medicine Society of 
Chinese Medical Association, China Alliance of COPD, China RTI Optimal Treatment 
Committee, Drug Clinical Assessment Committee of Chinese Pharmaceutical Association, is a 
peer-reviewed online journal with Quarterly print on demand compilation of issues 
published. The journal allows free access (Open Access) to its contents and permits authors 
to self-archive final accepted version of the articles on any OAI-compliant institutional / 
subject-based repository.  
 
 Scope of the journal   
The journal will cover technical and clinical studies related to health, ethical and social issues 
in field of Will cover all aspects of internal medicine including Respiratory diseases, 
Circulatory diseases, Gastroenterology, Urinary diseases, Haematology, Kidney diseases, 
Endocrinology, etc, but their focus is on translational application.. Articles with clinical 
interest and implications will be given preference.      
 
 The Editorial Process  
A manuscript will be reviewed for possible publication with the understanding that it is being 
submitted to Journal of Translational Internal Medicine alone at that point in time and has 
not been published anywhere, simultaneously submitted, or already accepted for 
publication elsewhere. The journal expects that authors would authorize one of them to 
correspond with the Journal for all matters related to the manuscript. All manuscripts 
received are duly acknowledged. On submission, editors review all submitted manuscripts 
initially for suitability for formal review. During this process, editors will also check if the 
manuscripts are prepared according to the Author Instructions and the “International 
Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, 
Editing and Publication of Scholarly Work in Medical Journals”(The Requirements, at 
http://www.icmje.org/recommendations/). Manuscripts with insufficient originality, serious 
scientific or technical flaws, or lack of a significant message are rejected before proceeding 
for formal peer-review. Manuscripts that are unlikely to be of interest to the readers of 
Journal of Translational Internal Medicine are also liable to be rejected at this stage itself.  
 
Manuscripts that are found suitable for publication in Journal of Translational Internal 
Medicine are sent to two or more expert reviewers. During submission, the contributor is 
requested to provide names of two or three qualified reviewers who have had experience in 
the subject of the submitted manuscript, but this is not mandatory. The reviewers should 
not be affiliated with the same institutes as the contributor/s. However, the selection of 
these reviewers is at the sole discretion of the editor. The journal follows a double-blind 
review process, wherein the reviewers and authors are unaware of each other’s identity. 
Every manuscript is also assigned to a member of the editorial team, who based on the 
comments from the reviewers takes a final decision on the manuscript. The comments and 
suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers 
are conveyed to the corresponding author. If required, the author is requested to provide a 
point by point response to reviewers’ comments and submit a revised version of the 
manuscript. This process is repeated till reviewers and editors are satisfied with the 
manuscript.  
 
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, 
and format. Page proofs are sent to the corresponding author. The corresponding author is 
expected to return the corrected proofs within three days. It may not be possible to 
incorporate corrections received after that period. The whole process of submission of the 
manuscript to final decision and sending and receiving proofs is completed online. To 
achieve faster and greater dissemination of knowledge and information, the journal 
publishes articles online as ‘Ahead of Print’ immediately on acceptance. 
 Clinical trial registry    
Journal of Translational Internal Medicine favors registration of clinical trials and is a 
signatory to the Statement on publishing clinical trials in international biomedical journals. 
Journal of Translational Internal Medicine would publish clinical trials that have been 
registered with a clinical trial registry that allows free online access to public.  
 Authorship Criteria  
Authorship credit should be based only on substantial contributions to each of the three 
components mentioned below:  
1. Concept and design of study or acquisition of data or analysis and interpretation of 
data; 
2. Drafting the article or revising it critically for important intellectual content; and 
3. Final approval of the version to be published. 
Participation solely in the acquisition of funding or the collection of data does not justify 
authorship. General supervision of the research group is not sufficient for authorship. Each 
contributor should have participated sufficiently in the work to take public responsibility for 
appropriate portions of the content of the manuscript. The order of naming the contributors 
should be based on the relative contribution of the contributor towards the study and 
writing the manuscript. Once submitted the order cannot be changed without written 
consent of all the contributors. The journal prescribes a maximum number of authors for 
manuscripts depending upon the type of manuscript, its scope and number of institutions 
involved (vide infra). The authors should provide a justification, if the number of authors 
exceeds these limits. 
 Contribution Details  
Contributors should provide a description of contributions made by each of them towards 
the manuscript. Description should be divided in following categories, as applicable: concept, 
design, definition of intellectual content, literature search, clinical studies, experimental 
studies, data acquisition, data analysis, statistical analysis, manuscript preparation, 
manuscript editing and manuscript review. Authors' contributions will be printed along with 
the article. One or more author should take responsibility for the integrity of the work as a 
whole from inception to published article and should be designated as 'guarantor'.  
 
 Conflicts of Interest/ Competing Interests  
All authors of must disclose any and all conflicts of interest they may have with publication 
of the manuscript or an institution or product that is mentioned in the manuscript and/or is 
important to the outcome of the study presented. Authors should also disclose conflict of 
interest with products that compete with those mentioned in their manuscript. 
 
Statement of Human and Animal Rights 
 
For research studies using human or animal subjects, the trial’s design, conduct and 
reporting of results must conform to Good Clinical Practice guidelines (such as the Good 
Clinical Practice in Food and Drug Administration (FDA)-Regulated Clinical Trials (USA) or the 
Medical Research Council Guidelines for Good Clinical Practice in Clinical Trials (UK)) and/or 
to the World Medical Association (WMA) Declaration of Helsinki. Generally, we suggest that 
the national standard of the lead investigator be followed. If authors have any doubt as to 
whether the research was conducted in accordance with the above standards, the rationale 
for the chosen experimental approach must be clearly presented, along with a statement 
and proof of explicit approval given by the appropriate Institutional Review Board (IRB, for 
human subjects) and/or the Institutional Animal Care and Use Committee (IACUC, for animal 
subjects) for conducting the doubtful aspects of the study. 
All research reports that are submitted for consideration of publication in a SMP journal 
must include statement(s) of proof that the appropriate approvals were obtained from the 
relevant IRB or research ethics committee. Any manuscript describing a study that used 
human subjects must include a statement that affirms the experiments were performed with 
prior informed consent (written or verbal, as appropriate) from each participant. All personal 
information must be anonymized prior to publication, unless a record of explicit consent 
from the involved patient(s) has been provided. Any manuscript describing a study that used 
animal subjects must include a statement in the Materials and Methods section (or text 
describing the experimental procedures) that affirms all appropriate measures were taken to 
minimize pain or discomfort, and details of the animals’ care should be provided. 
 
Informed Consent  
 
Any research article describing a study (clinical research and case report) involving humans 
should contain a statement in the title page clearly stating that all involved persons (subjects 
or legally authorized representative) gave their informed consent (written or verbal, as 
appropriate) prior to study inclusion. In general, SMP requires that any and all details that 
might disclose the identity of the subjects under study should be omitted or anonymized. In 
the rare situation that a study participant’s identifiable information is crucial to the case 
presentation, the statement of informed consent is absolutely necessary, unless the 
participant is deceased. In addition, a copy of any approval document(s)/letter(s) or waiver 
should be provided to the SMP in PDF format. 
 Submission of Manuscripts  
All manuscripts must be submitted on-line through the website. First time users will have to 
register at this site. Registration is free but mandatory. Registered authors can keep track of 
their articles after logging into the site using their user name and password. Authors do not 
have to pay for submission, processing or publication of articles. If you experience any 
problems, please contact the editorial office by e-mail at editor office@springpublishing.org. 
Authors are strongly recommended to read “The Requirements” as mentioned above 
(http://www.icmje.org/recommendations/) during the preparation of the papers. 
The submitted manuscripts that are not as per the “Instructions to Authors” would be 
returned to the authors for technical correction, before they undergo editorial/ peer-review. 
Generally, the manuscript should be submitted in the form of two separate files: 
[1] Title Page/First Page File/covering letter: 
This file should provide 
1. The type of manuscript (original article, case report, review article, Letter to editor, 
Images, etc.) title of the manuscript, running title, names of all authors/ contributors 
(with their highest academic degrees, designation and affiliations) and name(s) of 
department(s) and/ or institution(s) to which the work should be credited, . All 
information which can reveal your identity should be here. Use text/rtf/doc files. Do 
not zip the files. 
2. The total number of pages, total number of photographs and word counts separately 
for abstract and for the text (excluding the references, tables and abstract), word 
counts for introduction + discussion in case of an original article; 
3. Source(s) of support in the form of grants, equipment, drugs, or all of these; 
4. Acknowledgement, if any. One or more statements should specify 1) contributions 
that need acknowledging but do not justify authorship, such as general support by a 
departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments 
of financial and material support, which should specify the nature of the support. 
This should be included in the title page of the manuscript and not in the main article 
file. 
5. If the manuscript was presented as part at a meeting, the organization, place, and 
exact date on which it was read. A full statement to the editor about all submissions 
and previous reports that might be regarded as redundant publication of the same or 
very similar work. Any such work should be referred to specifically, and referenced in 
the new paper. Copies of such material should be included with the submitted paper, 
to help the editor decide how to handle the matter. 
6. Registration number in case of a clinical trial and where it is registered (name of the 
registry and its URL) 
7. Conflicts of Interest of each author/ contributor. A statement of financial or other 
relationships that might lead to a conflict of interest, if that information is not 
included in the manuscript itself or in an authors' form 
8. Criteria for inclusion in the authors’/ contributors’ list 
9. A statement that the manuscript has been read and approved by all the authors, that 
the requirements for authorship as stated earlier in this document have been met, 
and that each author believes that the manuscript represents honest work, if that 
information is not provided in another form (see below); and 
10. The name, address, e-mail, and telephone number of the corresponding author, who 
is responsible for communicating with the other authors about revisions and final 
approval of the proofs, if that information is not included on the manuscript itself. 
[2] Blinded Article file: The main text of the article, beginning from Abstract till References 
(including tables) should be in this file. The file must not contain any mention of the authors' 
names or initials or the institution at which the study was done or acknowledgements. Page 
headers/running title can include the title but not the authors' names. Manuscripts not in 
compliance with the Journal's blinding policy will be returned to the corresponding author. 
Use rtf/doc files. Do not zip the files. Limit the file size to 1 MB. Do not incorporate images 
in the file. If file size is large, graphs can be submitted as images separately without 
incorporating them in the article file to reduce the size of the file. The pages should be 
numbered consecutively, beginning with the first page of the blinded article file. 
[3] Images: Submit good quality color images. Each image should be less than 2 MB in size. 
Size of the image can be reduced by decreasing the actual height and width of the images 
(keep up to 1600 x 1200 pixels or 5-6 inches). Images can be submitted as jpeg files. Do not 
zip the files. Legends for the figures/images should be included at the end of the article file.  
[4] The contributors' / copyright transfer form (template provided below) has to be 
submitted in original with the signatures of all the contributors within two weeks of 
submission via courier, fax or email as a scanned image. Print ready hard copies of the 
images (one set) or digital images should be sent to the journal office at the time of 
submitting revised manuscript. High resolution images (up to 5 MB each) can be sent by 
email. 
 Preparation of Manuscripts  
Manuscripts must be prepared in accordance with "The Requirements" developed by the 
International Committee of Medical Journal Editors 
(http://www.icmje.org/recommendations/). The uniform requirements and specific 
requirement of Journal of Translational Internal Medicine are summarized below. Before 
submitting a manuscript, contributors are requested to check for the latest instructions 
available.  
Journal of Translational Internal Medicine accepts manuscripts written in American English. 
 Copies of any permission(s)  
It is the responsibility of authors/ contributors to obtain permissions for reproducing any 
copyrighted material. A copy of the permission obtained must accompany the manuscript. 
Copies of any and all published articles or other manuscripts in preparation or submitted 
elsewhere that are related to the manuscript must also accompany the manuscript. The 
material should be sent to any of the two addresses given above. 
 Types of Manuscripts  
Original articles: 
These include randomized controlled trials, intervention studies, studies of screening and 
diagnostic test, outcome studies, cost effectiveness analyses, case-control series, and 
surveys with high response rate. The text of original articles amounting to up to 3000 words 
(excluding Abstract, references and Tables) should be divided into sections with the headings 
Abstract, Key-words, Introduction, Material and Methods, Results, Discussion, References, 
Tables and Figure legends. 
Introduction: State the purpose and summarize the rationale for the study or observation.  
Materials and Methods: It should include and describe the following aspects: 
Materials and Methods: Selection and Description of Participants: Describe your selection of 
the observational or experimental participants (patients or laboratory animals, including 
controls) clearly, including eligibility and exclusion criteria and a description of the source 
population. Technical information: Identify the methods, apparatus (give the manufacturer's 
name and address in parentheses), and procedures in sufficient detail to allow other workers 
to reproduce the results. Give references to established methods, including statistical 
methods (see below); provide references and brief descriptions for methods that have been 
published but are not well known; describe new or substantially modified methods, give 
reasons for using them, and evaluate their limitations. Identify precisely all drugs and 
chemicals used, including generic name(s), dose(s), and route(s) of administration. 
 
Reports of randomized clinical trials should present information on all major study elements, 
including the protocol, assignment of interventions (methods of randomization, 
concealment of allocation to treatment groups), and the method of masking (blinding), 
based on the CONSORT Statement (http://www.consort-statement.org). 
 
Statistics: Whenever possible quantify findings and present them with appropriate 
indicators of measurement error or uncertainty (such as confidence intervals). Authors 
should report losses to observation (such as, dropouts from a clinical trial). When data are 
summarized in the Results section, specify the statistical methods used to analyze them. 
Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a 
randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical 
terms, abbreviations, and most symbols. Specify the computer software used. Use upper 
italics (P0.048). For all P values include the exact value and not less than 0.05 or 0.001. Mean 
differences in continuous variables, proportions in categorical variables and relative risks 
including odds ratios and hazard ratios should be accompanied by their confidence intervals. 
 
Results: Present your results in a logical sequence in the text, tables, and illustrations, giving 
the main or most important findings first. Do not repeat in the text all the data in the tables 
or illustrations; emphasize or summarize only important observations. Extra- or 
supplementary materials and technical detail can be placed in an appendix where it will be 
accessible but will not interrupt the flow of the text; alternatively, it can be published only in 
the electronic version of the journal. 
 
When data are summarized in the Results section, give numeric results not only as 
derivatives (for example, percentages) but also as the absolute numbers from which the 
derivatives were calculated, and specify the statistical methods used to analyze them. 
Restrict tables and figures to those needed to explain the argument of the paper and to 
assess its support. Use graphs as an alternative to tables with many entries; do not duplicate 
data in graphs and tables. Where scientifically appropriate, analyses of the data by variables 
such as age and sex should be included. 
 
Discussion: Include summary of key findings (primary outcome measures, secondary 
outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of 
the study (study question, study design, data collection, analysis and 
interpretation); Interpretation and implications in the context of the totality of evidence (is 
there a systematic review to refer to, if not, could one be reasonably done here and now?, 
what this study adds to the available evidence, effects on patient care and health policy, 
possible mechanisms); Controversies raised by this study; and Future research directions (for 
this particular research collaboration, underlying mechanisms, clinical research).  
Do not repeat in detail data or other material given in the Introduction or the Results 
section. In particular, contributors should avoid making statements on economic benefits 
and costs unless their manuscript includes economic data and analyses. Avoid claiming 
priority and alluding to work that has not been completed. New hypotheses may be stated if 
needed, however they should be clearly labeled as such. About 30 references can be 
included. These articles generally should not have more than six authors. 
 
Review Articles: 
It is expected that these articles would be written by individuals who have done substantial 
work on the subject or are considered experts in the field. A short summary of the work 
done by the contributor(s) in the field of review should accompany the manuscript. 
The prescribed word count is up to 3000 words excluding tables, references and abstract. 
The manuscript may have about 90 references. The manuscript should have an unstructured 
Abstract (250 words) representing an accurate summary of the article. The section titles 
would depend upon the topic reviewed. Authors submitting review article should include a 
section describing the methods used for locating, selecting, extracting, and synthesizing data. 
These methods should also be summarized in the abstract. 
The journal expects the contributors to give post-publication updates on the subject of 
review. The update should be brief, covering the advances in the field after the publication 
of the article and should be sent as a letter to editor, as and when major development 
occurs in the field. 
Case reports: 
New, interesting and rare cases can be reported. They should be unique, describing a great 
diagnostic or therapeutic challenge and providing a learning point for the readers. Cases 
with clinical significance or implications will be given priority. These communications could 
be of up to 1000 words (excluding Abstract and references) and should have the following 
headings: Abstract (unstructured), Key-words, Introduction, Case report, Discussion, 
Reference, Tables and Legends in that order. 
The manuscript could be of up to 1000 words (excluding references and abstract) and could 
be supported with up to 10 references. Case Reports could be authored by up to four 
authors. 
Letter to the Editor: 
These should be short and decisive observations. They should preferably be related to 
articles previously published in the Journal or views expressed in the journal. They should 
not be preliminary observations that need a later paper for validation. The letter could have 
up to 500 words and 5 references. It could be generally authored by not more than four 
authors. 
Other: 
Editorial, Guest Editorial, Commentary and Opinion are solicited by the editorial board. 
References 
References should be numbered consecutively in the order in which they are first mentioned 
in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic 
numerals in superscript with square bracket after the punctuation marks. References cited 
only in tables or figure legends should be numbered in accordance with the sequence 
established by the first identification in the text of the particular table or figure. Use the style 
of the examples below, which are based on the formats used by the NLM in Index Medicus. 
The titles of journals should be abbreviated according to the style used in Index Medicus. 
Use complete name of the journal for non-indexed journals. Avoid using abstracts as 
references. Information from manuscripts submitted but not accepted should be cited in the 
text as "unpublished observations" with written permission from the source. Avoid citing a 
"personal communication" unless it provides essential information not available from a 
public source, in which case the name of the person and date of communication should be 
cited in parentheses in the text.  
The commonly cited types of references are shown here, for other types of references such 
as newspaper items please refer to ICMJE Guidelines (http://www.icmje.org 
or http://www.nlm.nih.gov/bsd/uniform_requirements.html). 
Articles in Journals 
1. Standard journal article (for up to six authors): Parija S C, Ravinder PT, Shariff 
M. Detection of hydatid antigen in the fluid samples from hydatid cysts by co-
agglutination. Trans. R.Soc. Trop. Med. Hyg.1996; 90:255–256. 
2. Standard journal article (for more than six authors): List the first six contributors 
followed by et al.  
Roddy P, Goiri J, Flevaud L, Palma PP, Morote S, Lima N. et al., Field Evaluation of a Rapid 
Immunochromatographic Assay for Detection of Trypanosoma cruzi Infection by Use of 
Whole Blood. J. Clin. Microbiol. 2008; 46: 2022-2027. 
3. Volume with supplement: Otranto D, Capelli G, Genchi C: Changing distribution 
patterns of canine vector borne diseases in Italy: leishmaniosis vs. 
dirofilariosis.Parasites & Vectors 2009; Suppl 1:S2.  
Books and Other Monographs 
1. Personal author(s): Parija SC. Textbook of Medical Parasitology. 3rd ed. All India 
Publishers and Distributors. 2008. 
2. Editor(s), compiler(s) as author: Garcia LS, Filarial Nematodes In: Garcia LS (editor) 
Diagnostic Medical Parasitology ASM press Washington DC 2007: pp 319-356. 
3. Chapter in a book: Nesheim M C. Ascariasis and human nutrition. In Ascariasis and its 
prevention and control, D. W. T. Crompton, M. C. Nesbemi, and Z. S. Pawlowski (eds.). 
Taylor and Francis,London, U.K.1989, pp. 87–100. 
Electronic Sources as reference 
Journal article on the Internet: Parija SC, Khairnar K. Detection of excretory Entamoeba 
histolytica DNA in the urine, and detection of E. histolytica DNA and lectin antigen in the liver 
abscess pus for the diagnosis of amoebic liver abscess .BMC 
Microbiology2007, 7:41.doi:10.1186/1471-2180-7-1. http://www.biomedcentral.com/1471-
2180/7/41 
 
Tables 
 Tables should be self-explanatory and should not duplicate textual material. 
 Number tables, in Arabic numerals, consecutively in the order of their first citation in 
the text and supply a brief title for each. 
 Place explanatory matter in footnotes, not in the heading. 
 Explain in footnotes all non-standard abbreviations that are used in each table. 
 Obtain permission for all fully borrowed, adapted, and modified tables and provide a 
credit line in the footnote. 
 For footnotes use the following symbols, in this sequence: *, †, ‡, §, ||,¶ , **, ††, ‡‡ 
 Tables with their legends should be provided at the end of the text after the 
references. The tables along with their number should be cited at the relevant place 
in the text 
Illustrations (Figures) 
 Upload the images in JPEG format. The file size should be within 1024 kb in size while 
uploading. 
 Figures should be numbered consecutively according to the order in which they have 
been first cited in the text. 
 Labels, numbers, and symbols should be clear and of uniform size. The lettering for 
figures should be large enough to be legible after reduction to fit the width of a 
printed column. 
 Symbols, arrows, or letters used in photomicrographs should contrast with the 
background and should be marked neatly with transfer type or by tissue overlay and 
not by pen. 
 Titles and detailed explanations belong in the legends for illustrations not on the 
illustrations themselves. 
 When graphs, scatter-grams or histograms are submitted the numerical data on 
which they are based should also be supplied. 
 The photographs and figures should be trimmed to remove all the unwanted areas. 
 If photographs of individuals are used, their pictures must be accompanied by 
written permission to use the photograph. 
 If a figure has been published elsewhere, acknowledge the original source and submit 
written permission from the copyright holder to reproduce the material. A credit line 
should appear in the legend for such figures. 
 Legends for illustrations: Type or print out legends for illustrations using double 
spacing, with Arabic numerals corresponding to the illustrations. When symbols, 
arrows, numbers, or letters are used to identify parts of the illustrations, identify and 
explain each one in the legend. Explain the internal scale (magnification) and identify 
the method of staining in photomicrographs. 
 Final figures for print production: Send sharp, glossy, un-mounted, color 
photographic prints, with height of 4 inches and width of 6 inches at the time of 
submitting the revised manuscript. Print outs of digital photographs are not 
acceptable. If digital images are the only source of images, ensure that the image has 
minimum resolution of 300 dpi or 1800 x 1600 pixels in TIFF format. The Journal 
reserves the right to crop, rotate, reduce, or enlarge the photographs to an 
acceptable size.  
Protection of Patients' Rights to Privacy   
Identifying information should not be published in written descriptions, photographs, 
sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific 
purposes and the patient (or parent or guardian, wherever applicable) gives written 
informed consent for publication. Authors should remove patients' names from figures 
unless they have obtained written informed consent from the patients. When informed 
consent has been obtained, it should be indicated in the article and copy of the consent 
should be attached with the covering letter.  
Sending a revised manuscript   
The revised version of the manuscript should be submitted online in a manner similar to that 
used for submission of the manuscript for the first time. However, there is no need to 
submit the “First Page” or “Covering Letter” file while submitting a revised version. When 
submitting a revised manuscript, contributors are requested to include, the ‘referees’ 
remarks along with point to point clarification at the beginning in the revised file itself. In 
addition, they are expected to mark the changes as underlined or colored text in the article. 
Reprints and proofs   
Journal provides no free printed reprints. Authors can purchase reprints, payment for which 
should be done at the time of submitting the proofs. 
Manuscript submission, processing and publication charges   
Journal does not charge for submission or publication fee on article. 
Copyrights    
The entire contents of the Journal of Translational Internal Medicine are protected under 
international copyrights. The Journal, however, grants to all users a free, irrevocable, 
worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and 
display the work publicly and to make and distribute derivative works in any digital medium 
for any reasonable non-commercial purpose, subject to proper attribution of authorship and 
ownership of the rights. The journal also grants the right to make small numbers of printed 
copies for their personal non-commercial use under Creative Commons Attribution-
Noncommercial-Share Alike 3.0 Unported License. 
 
Checklist    
Covering letter 
 Signed by all contributors 
 Previous publication / presentations mentioned 
 Source of funding mentioned 
 Conflicts of interest disclosed 
Authors 
 Last name and given name provided along with Middle name initials (where 
applicable) 
 Author for correspondence, with e-mail address provided 
 Number of contributors restricted as per the instructions 
 Identity not revealed in paper except title page (e.g. name of the institute in Methods, 
citing previous study as 'our study', names on figure labels, name of institute in 
photographs, etc.) 
Presentation and format 
 Double spacing 
 Margins 2.5 cm from all four sides 
 Page numbers included at bottom 
 Title page contains all the desired information 
 Running title provided (not more than 50 characters) 
 Abstract page contains the full title of the manuscript 
 Abstract provided (structured abstract of 250 words for original articles, unstructured 
abstracts of about 150 words for all other manuscripts excluding letters to the Editor) 
 Key words provided (three or more) 
 Introduction of 75-100 words 
 Headings in title case (not ALL CAPITALS) 
 The references cited in the text should be after punctuation marks, in superscript 
with square bracket. 
 References according to the journal's instructions, punctuation marks checked 
 Send the article file without ‘Track Changes’ 
Language and grammar 
 Uniformly American English 
 Write the full term for each abbreviation at its first use in the title, abstract, 
keywords and text separately unless it is a standard unit of measure. Numerals from 
1 to 10 spelt out 
 Numerals at the beginning of the sentence spelt out 
 Check the manuscript for spelling, grammar and punctuation errors 
 If a brand name is cited, supply the manufacturer's name and address (city and 
state/country). 
 Species names should be in italics 
Tables and figures 
 No repetition of data in tables and graphs and in text 
 Actual numbers from which graphs drawn, provided 
 Figures necessary and of good quality (colour) 
 Table and figure numbers in Arabic letters (not Roman) 
 Labels pasted on back of the photographs (no names written) 
 Figure legends provided (not more than 40 words) 
 Patients' privacy maintained (if not permission taken) 
 Credit note for borrowed figures/tables provided 
 Write the full term for each abbreviation used in the table as a footnote 
 
 
